semaglutide cardiovascular outcomes news 2025 october and in Obesity without Diabetes: The SELECT Trial Semaglutide lowers cardiovascular events even

It has been shown to upregulate the expression of growth-factor receptors on tendon fibroblasts, promote the formation of new blood vessels (angiogenesis) partly through the VEGF and nitric-oxide pathways, and encourage fibroblast migration and proliferation

Their standard titration protocol starts at 3mg daily for the first four weeks, then increases to 4mg daily for maintenance

You might find that your usual breakfast suddenly feels too large, or afternoon snacking loses its appeal

Br J Nutr, 2003

However, semaglutide is not a quick fix or a miracle treatment

This improves the oxygen-efficiency of energy production and reduces infarct expansion and arrhythmic substrate